<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02813187</url>
  </required_header>
  <id_info>
    <org_study_id>CDR006</org_study_id>
    <nct_id>NCT02813187</nct_id>
  </id_info>
  <brief_title>Venous Leg Ulcer and Lymphedema Registry</brief_title>
  <acronym>VLULR</acronym>
  <official_title>A Real World, Observational Registry of Venous Leg Ulcers and Quality of Care in Clinical Practice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>U.S. Wound Registry</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>U.S. Wound Registry</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational, longitudinal real world registry of venous leg ulcers created from&#xD;
      electronic health record data obtained in the course of clinical care. Data from certified&#xD;
      electronic health records transmit data as part of the requirement to share data with a&#xD;
      specialty registry under Objective 10 of Meaningful Use of an EHR.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational, longitudinal real world registry of venous leg ulcers created from&#xD;
      electronic health record data obtained in the course of clinical care. Data from certified&#xD;
      electronic health records transmit data as part of the requirement to share data with a&#xD;
      specialty registry under Objective 10 of Meaningful Use of an EHR. No secondary data entry&#xD;
      are required and all data are obtained via structured language from data entered in the EHR.&#xD;
      Data from quality measures designed as electronic clinical quality measures (eCQMs)&#xD;
      standardize the quality of care provided to patients and their clinical outcomes which are&#xD;
      risk stratified using the Wound Healing Index (WHI). The eCQMs enable standardized data&#xD;
      collection and the ability to transmit data electronically obviates the possibility of&#xD;
      transcription errors. National bench marking is possible since data are available from&#xD;
      thousands of participants across the USA. While an independent IRB oversees this project, the&#xD;
      data are collected for the purpose of measuring and improving the quality of care delivered&#xD;
      to diabetic patients with foot ulcers and understanding their outcomes in relation to level&#xD;
      of risk. Quality performance is reported as part of PQRS. These functions are exempt from the&#xD;
      requirements of informed consent.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">May 2016</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">May 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Wound Healing</measure>
    <time_frame>12 months</time_frame>
    <description>wound closure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weeks of Therapy</measure>
    <time_frame>12 months</time_frame>
    <description>days from initial visit to discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events during therapy</measure>
    <time_frame>12 months</time_frame>
    <description>hospitalization, cellulitis, amputation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcome</measure>
    <time_frame>12 months</time_frame>
    <description>using patient reported outcome quality measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Venous Insufficiency</measure>
    <time_frame>12 months</time_frame>
    <description>secondary lymphedema and its relationship to venous insufficiency</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Venous Stasis Ulcer</condition>
  <condition>Quality of Patient Care</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>cellular and tissue based therapy</intervention_name>
    <other_name>Apligraf</other_name>
    <other_name>Dermagraft</other_name>
    <other_name>Theraskin</other_name>
    <other_name>Epifix</other_name>
    <other_name>Dermapure</other_name>
    <other_name>Grafix</other_name>
    <other_name>Talymed</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>debridement</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>advanced wound therapy</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nutritional screening</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Prospectively followed venous leg ulcers in the practice of clinicians submitting data to&#xD;
        the registry&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients with venous leg ulcers seen by the practitioner.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHI St. Luke's The Woodlands</name>
      <address>
        <city>The Woodlands</city>
        <state>Texas</state>
        <zip>77384</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>June 10, 2016</study_first_submitted>
  <study_first_submitted_qc>June 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2016</study_first_posted>
  <last_update_submitted>April 23, 2018</last_update_submitted>
  <last_update_submitted_qc>April 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>venous leg ulcer</keyword>
  <keyword>venous</keyword>
  <keyword>QCDR</keyword>
  <keyword>quality measure</keyword>
  <keyword>wound</keyword>
  <keyword>Outcome</keyword>
  <keyword>Lymphedema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

